Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Centessa Pharmaceuticals plc | StockGist | StockGist

Companies
CNTA
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings CNTASCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Centessa Pharmaceuticals plc

Filed Feb 17, 2026

Accepted Feb 16, 2026, 7:00 PM ET

CIK 0001847903

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

146,049,056

Reporting Person

Centessa Pharmaceuticals plc

Person Type

IA

CUSIP: 152309100

Amendment History

3 filings

SCHEDULE 13G
Original
Nov 14, 20250000902664-25-004944
SCHEDULE 13G/A
Amendment 1
Aug 12, 20250000902664-25-003498
SCHEDULE 13G/A
Amendment 2
Latest
Viewing
Feb 17, 20260000902664-26-001025

Key Facts

Shares Owned

146,049,056

Recent Filings

Centessa Pharmaceuticals plc5 days ago

Centessa Pharmaceuticals plc5 days ago

Centessa Pharmaceuticals plc1 months ago

Centessa Pharmaceuticals plc1 months ago

Centessa Pharmaceuticals plc1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice